OTC:MRMD MariMed (MRMD) Stock Price, News & Analysis $0.10 0.00 (-3.75%) As of 05/9/2025 03:46 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsBuy This Stock About MariMed Stock (OTC:MRMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MariMed alerts:Sign Up Key Stats Today's Range$0.10▼$0.1050-Day Range$0.08▼$0.1252-Week Range$0.07▼$0.29Volume271,382 shsAverage Volume388,655 shsMarket Capitalization$36.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingStrong Buy Company OverviewMariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Read More… Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Email Address MRMD Stock News HeadlinesEarnings call transcript: Marimed’s Q1 2025 revenue flat, stock edges upMay 9 at 10:28 AM | investing.comMariMed Inc. (PNK:MRMD) Q1 2025 Earnings Call TranscriptMay 9 at 10:28 AM | insidermonkey.comThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.May 12, 2025 | Stansberry Research (Ad)MariMed Inc (MRMD) Q1 2025 Earnings Call Highlights: Strategic Expansion Amidst Market ChallengesMay 9 at 10:28 AM | finance.yahoo.comMariMed Inc. (MRMD) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comMarimed appoints Ryan Crandall as CCOApril 8, 2025 | markets.businessinsider.comNoble Financial Sticks to Their Buy Rating for MariMed (MRMD)April 5, 2025 | markets.businessinsider.comMarimed initiated with an Outperform at Noble CapitalApril 5, 2025 | markets.businessinsider.comSee More Headlines MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed this year? MariMed's stock was trading at $0.1158 at the beginning of the year. Since then, MRMD shares have decreased by 18.0% and is now trading at $0.0950. View the best growth stocks for 2025 here. How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTC:MRMD CIK1522767 Webwww.marimedinc.com Phone(781) 277-0007FaxN/AEmployees260Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,030,000.00 Net Margins-8.95% Pretax Margin-6.55% Return on Equity1.58% Return on Assets0.53% Debt Debt-to-Equity Ratio1.08 Current Ratio1.27 Quick Ratio0.49 Sales & Book Value Annual Sales$148.60 million Price / Sales0.25 Cash Flow$0.02 per share Price / Cash Flow4.60 Book Value$0.19 per share Price / Book0.50Miscellaneous Outstanding Shares388,710,000Free Float309,044,000Market Cap$36.93 million OptionableN/A Beta3.15 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTC:MRMD) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis next market event could mean total financial ruin for someYou think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MariMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.